94 related articles for article (PubMed ID: 21434990)
1. Transgene number-dependent, gene expression rate-independent rejection of Dd -, Kd-, or Dd Kd -transgened mouse skin or tumor cells from C57BL/6 Db Kb mice.
Inoue Y; Tashiro-Yamaji J; Hayashi M; Kiyonari H; Shimizu T; Ibata M; Yamana H; Kubota T; Tanigawa N; Yoshida R
Microbiol Immunol; 2011 Jun; 55(6):446-53. PubMed ID: 21434990
[TBL] [Abstract][Full Text] [Related]
2. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
[TBL] [Abstract][Full Text] [Related]
3. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
4. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
Margenthaler JA; Landeros K; Kataoka M; Flye MW
Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of L(d+) transgenic mouse hearts.
Margenthaler JA; Tu F; Otomo N; Shimizu Y; Yu S; Flye MW
Surgery; 2001 Aug; 130(2):217-24. PubMed ID: 11490352
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
9. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
Tashiro-Yamaji J; Kubota T; Yoshida R
Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
[TBL] [Abstract][Full Text] [Related]
10. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
[TBL] [Abstract][Full Text] [Related]
11. Peripheral tolerance in transgenic mice expressing class I MHC L(d) only on cardiac cells.
Margenthaler JA; Kataoka M; Flye MW
Transpl Immunol; 2004 Jan; 12(2):133-41. PubMed ID: 14967311
[TBL] [Abstract][Full Text] [Related]
12. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
Ramos A; Merino R; Merino J
Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
[TBL] [Abstract][Full Text] [Related]
13. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
[TBL] [Abstract][Full Text] [Related]
14. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.
Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF
Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991
[TBL] [Abstract][Full Text] [Related]
16. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
[TBL] [Abstract][Full Text] [Related]
17. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
19. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
Nevala WK; Paul C; Wettstein PJ
J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
[TBL] [Abstract][Full Text] [Related]
20. IL-5 mediates eosinophilic rejection of MHC class II-disparate skin allografts in mice.
Le Moine A; Surquin M; Demoor FX; Noël JC; Nahori MA; Pretolani M; Flamand V; Braun MY; Goldman M; Abramowicz D
J Immunol; 1999 Oct; 163(7):3778-84. PubMed ID: 10490975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
